Stem Cell Consortium

The Columbia University Stem Cell Consortium is a community of researchers from a variety of medical and scientific disciplines. Their investigative efforts strive to translate basic science studies into clinical treatments that will defeat the advancement of many chronic and untreatable diseases.

The Stem Cell Consortium is deeply committed to the conversion of stem cells into a source of future cell-based therapies.

• to study the normal birth, maturation and death of cells;
• to repair or replace cells or tissues that are damaged or destroyed by many of our most devastating diseases and disabilities, such as ALS, Parkinson's, juvenile diabetes, as well as brain injury stroke;
• to employ stem cells from humans and animal models to study mechanisms of human diseases; and
• as a tool to develop new drug therapies

Columbia University is a premier stem cell research institution. The university’s unparalleled track record in neuroscience, developmental biology, and cell replacement therapy places Columbia in an ideal position to advance this emerging field. Stem cell research has the potential to revolutionize the practice of medicine, offering hope for restoration to patients affected by disabling diseases such as stroke, Parkinson's, and spinal cord injury.